SanBio Company Limited (TYO:4592)
Japan · Delayed Price · Currency is JPY 950.00
-21.00 (-2.16%)
Aug 6, 2026, 11:30 AM JST
SanBio Company Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
75.79B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2026 | - | - | - |
| Jan 31, 2025 | - | - | - |
| Jan 31, 2024 | - | - | - |
| Jan 31, 2023 | - | - | - |
| Jan 31, 2022 | - | - | - |
| Jan 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nxera Pharma | 34.23B |
| GNI Group | 27.05B |
| PeptiDream | 19.05B |
| Heartseed | 3.03B |
| Japan Tissue Engineering | 2.52B |
| AnGes | 908.00M |
| Cuorips | 212.00M |
| Healios K.K. | 74.00M |
SanBio Company News
- 7 weeks ago - SanBio Company Quarterly report: Q1 2027 - Filings
- 4 months ago - SanBio Company Earnings Call Transcript: Q4 2026 - Transcripts
- 4 months ago - SanBio Company Quarterly report: Q4 2026 - Filings
- 4 months ago - SanBio Company Slides: Q4 2026 - Filings
- 8 months ago - SanBio Company Quarterly report: Q3 2026 - Filings
- 11 months ago - SanBio Company Earnings Call Transcript: Q2 2026 - Transcripts
- 11 months ago - SanBio Company Quarterly report: Q2 2026 - Filings
- 11 months ago - SanBio Company Slides: Q2 2026 - Filings